COVID-19 vaccination in Greece

Last updated
COVID-19 vaccination in Greece
Native name Εθνική Εκστρατεία Εμβολιασμού «Επιχείρηση Ελευθερία»
Date27 December 2020 (2020-12-27) – present
LocationGreece
Cause COVID-19 pandemic in Greece
TargetFull immunisation of people in Greece against COVID-19
Participants21.091.153 doses administered
(30 June 2022)
7.919.254 have received at least one vaccine dose (30 June 2022)
75.4%
7.629.060 have received both vaccine doses (30 June 2022)
72.6%
6.119.231 have received a booster shot (30 June 2022)
58.2%
Website Official Website

The COVID-19 vaccination campaign in Greece began on 27 December 2020. [1] As of the 30th of June 2022, 7.919.254 people have received their first dose (75.4% of total population), and 7.629.060 people have been fully vaccinated (72.6% of total population). A total of 6.119.231 people have received an additional booster shot (58.2% of total population). [2]

Vaccines on order

There are several COVID-19 vaccines at various stages of development around the world.

VaccineApprovalDeployment
Pfizer–BioNTech Green check.svg 21 December 2020Green check.svg 27 December 2020
Moderna Green check.svg 6 January 2021Green check.svg 12 January 2021
Oxford-AstraZeneca Green check.svg 29 January 2021Green check.svg 7 February 2021
Janssen Green check.svg 11 March 2021Green check.svg 5 May 2021
Novavax Green check.svg 20 December 2021Green check.svg 5 March 2022

Related Research Articles

<span class="mw-page-title-main">COVID-19 pandemic in Latvia</span> Ongoing COVID-19 viral pandemic in Latvia

The COVID-19 pandemic in Latvia was a part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Latvia on 2 March 2020, having been brought along with people returning from abroad.

The COVID-19 pandemic was confirmed to have reached the French overseas collectivity of New Caledonia on 18 March 2020. All cases are on the main island of Grand Terre and are related to travel abroad. On 7 May, all cases had recovered.

<span class="mw-page-title-main">Sinopharm BIBP COVID-19 vaccine</span> Vaccine against COVID-19

The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed by Sinopharm's Beijing Institute of Biological Products. It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. BBIBP-CorV shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19. Its product name is SARS-CoV-2 Vaccine, not to be confused with the similar product name of CoronaVac.

<span class="mw-page-title-main">COVID-19 vaccination in the United Kingdom</span> Immunisation against COVID-19

The COVID-19 vaccination programme in the United Kingdom is an ongoing mass immunisation campaign for coronavirus disease 2019 (COVID-19) during the COVID-19 pandemic in the United Kingdom.

<span class="mw-page-title-main">COVID-19 vaccination in Sweden</span> Plan to immunize against COVID-19

Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden, the Public Health Agency has been commissioned by the government to create a vaccination plan. Sveriges riksbank, the central bank of Sweden, predicts that efficient vaccination against COVID-19 has macroeconomic benefits. As of 20 April 2022, 87.1% of people in Sweden have received at least one dose, with a total of 21,491,717 doses administered. At least one vaccine has been approved for all age groups 12 and older. Children younger than 12 in high risk groups can also be vaccinated.

<span class="mw-page-title-main">COVID-19 vaccination in India</span> Immunisation programme against COVID-19 in India

India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023, India has administered over 2.2 billion doses overall, including first, second and precautionary (booster) doses of the currently approved vaccines. In India, 95% of the eligible population (12+) has received at least one shot, and 88% of the eligible population (12+) is fully vaccinated.

<span class="mw-page-title-main">COVID-19 vaccination in Albania</span>

The COVID-19 vaccination campaign in Albania is a mass immunization campaign that was put in place by the Albanian authorities in order to respond to the ongoing COVID-19 pandemic. It started on 11 January 2021.

<span class="mw-page-title-main">COVID-19 vaccination in Russia</span> Plan to immunize against COVID-19

The COVID-19 vaccination campaign in Russia is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Russia became the first country to begin a mass COVID-19 vaccination programme on 5 December 2020, starting with primarily doctors, medical workers and teachers. In January 2021, this was extended to the entire population.

<span class="mw-page-title-main">COVID-19 vaccination in Zimbabwe</span> Plan to immunize against COVID-19

On 22 February 2021, Zimbabwe launched their national COVID-19 vaccination program using the Sinopharm BIBP vaccine. As of 17 June 2022, 6,260,228 people have received their first dose, 4,598,703 have received their second dose, and 851,874 have received a third dose.

On 29 January 2021, Algeria launched a COVID-19 vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June 2021, around 2.5 million doses have been administered. Algeria is currently vaccinating its population with both Sputnik V and Oxford-AstraZeneca vaccines.

COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. As of 15 June 2021, Angola has administered 1,314,375 doses of vaccines.822,109 people with the first dose and 492,266 people fully vaccinated. Angola began their vaccination program shortly after receiving their first shipment of Oxford AstraZeneca vaccine in early March 2021.

<span class="mw-page-title-main">COVID-19 vaccination in Africa</span> Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. In June 2021, the World Health Organization predicted that 47 of Africa's 54 nations would fall short of the aim of vaccinating 10% of their people by September 2021. In June, Africa accounted for fewer than 1% of worldwide vaccine doses delivered. Africa received in total less than 2% of the 3 billion vaccination doses provided globally.

<span class="mw-page-title-main">COVID-19 vaccination in Croatia</span> Plan to immunize against COVID-19

During the COVID-19 pandemic in Croatia, vaccination against COVID-19 began on 27 December 2020. The Croatian government ordered vaccines together with the EU. 8.7 million doses have been ordered. As of 3 February 2022, over 2.2 million people were fully vaccinated, corresponding to a 63% vaccination rate of the country's population.

<span class="mw-page-title-main">COVID-19 vaccination in Nigeria</span> Plan to immunize against COVID-19

COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021. As of 28 February 2022, 17,914,944 people have received their first dose a COVID-19 vaccine, and 8,197,832 have received their second dose.

<span class="mw-page-title-main">COVID-19 vaccination in Germany</span> Plan to immunize against COVID-19

The COVID-19 vaccination campaign in Germany began on 26 December 2020.

<span class="mw-page-title-main">COVID-19 vaccination in Singapore</span> Plan to immunize against COVID-19

The COVID-19 vaccination in Singapore is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Singapore has a very high vaccination rate, with more than 92% of its total population having completed their vaccination regimen.

COVID-19 vaccination in Iceland is an effort to immunize the adult population of Iceland due to the COVID-19 pandemic. As of July 2021, more than 260,000 individuals had received at least one dose of COVID-19 vaccine, which was over 78% of the country's population. On November 21, 2021, 90% of the target population had been fully vaccinated, while around 1 in 5 people had received a booster on top of that; by December 9, 2021, the share of the population having received a booster shot exceeded 50%. On December 13, 2021, the country began offering Pfizer vaccinations to children aged 5–11.

<span class="mw-page-title-main">COVID-19 vaccination in Taiwan</span> Plan to immunize against COVID-19

COVID-19 vaccination in Taiwan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country.

<span class="mw-page-title-main">COVID-19 vaccination in Spain</span> Immunization plan against COVID-19 in Spain

The COVID-19 vaccination in Spain is the national vaccination strategy started on the 27th of December 2020 in order to vaccinate the country's population against COVID-19 within the international effort to fight the COVID-19 pandemic.

<span class="mw-page-title-main">COVID-19 vaccination in Ukraine</span> Plan to immunize against COVID-19

The COVID-19 vaccination campaign in Ukraine is an ongoing mass immunization campaign for the COVID-19 pandemic in Ukraine.

References

  1. Newsroom (27 December 2020). "Γεγονός οι πρώτοι εμβολιασμοί στην Ελλάδα κατά της Covid-19 | Η ΚΑΘΗΜΕΡΙΝΗ". www.kathimerini.gr. Retrieved 2021-04-11.
  2. "COVID-19 vaccination statistics". www.data.gov.gr. Archived from the original on 2021-01-05. Retrieved 2021-04-25.